AR016684A1 - Composicion seca y solida para administracion de farmacos, proceso para su preparacion y el uso de una pluralidad de perlas que contienen una matrizpolimerica para la elaboracion de dicha composicion. - Google Patents
Composicion seca y solida para administracion de farmacos, proceso para su preparacion y el uso de una pluralidad de perlas que contienen una matrizpolimerica para la elaboracion de dicha composicion.Info
- Publication number
- AR016684A1 AR016684A1 ARP980105800A ARP980105800A AR016684A1 AR 016684 A1 AR016684 A1 AR 016684A1 AR P980105800 A ARP980105800 A AR P980105800A AR P980105800 A ARP980105800 A AR P980105800A AR 016684 A1 AR016684 A1 AR 016684A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- preparation
- solid
- dry
- oily
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion seca y solida para administracion de fármacos que está constituida por (i) por lo menos una sustancia grasosa, oleosa o pegajosa y por lomenos una sustancia farmacéuticamente activa o (ii)por lo menos una sustancia grasosa, oleosa op egajosa farmacéuticamente activa, que se caracteriza porpresentarse en forma de una pluralidad de perlas que contienen una matriz polimérica compuesta por un polietilenglicol o una mezcla de polietilenglicoles queson solidos a temperaturaambiente, y por exhibir, dicha composicion, características de liberacion rápida y por contener de 14% en peso a 70% en peso delcomponente (i) o (ii), proceso para su preparacion y el uso de una pluralidad de perlas que contienen una matrizpolimérica para la e laboracion de dichacomposicion. Un sistema de administracion de fármacos en forma solida seca de una o más sustancias grasosas, oleosas o pegajosas (en adelante g/o/p y una o mássustancias farmacéuticamente activas que de por síes/son g/o/p y que se caracteriza por constar de una pluralidad de perlas de matríz polimérica solida quecontienen cantidades considerables de sustancias g/o/p que tienen características de liberacion rápida puede contribuir a superar losinconvenientes asociadoscon los sistemas anteriores y (cuando es aplicable) facilitar la administracion simultánea de dos componentes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704401A SE9704401D0 (sv) | 1997-11-28 | 1997-11-28 | Matrix pellets for greasy, oily or sticky drug substances |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016684A1 true AR016684A1 (es) | 2001-07-25 |
Family
ID=20409178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105800A AR016684A1 (es) | 1997-11-28 | 1998-11-16 | Composicion seca y solida para administracion de farmacos, proceso para su preparacion y el uso de una pluralidad de perlas que contienen una matrizpolimerica para la elaboracion de dicha composicion. |
Country Status (23)
Country | Link |
---|---|
US (2) | US6555138B1 (es) |
EP (1) | EP1032371B1 (es) |
JP (1) | JP2001524514A (es) |
KR (1) | KR20010032558A (es) |
CN (1) | CN1280493A (es) |
AR (1) | AR016684A1 (es) |
AT (1) | ATE286382T1 (es) |
AU (1) | AU746324B2 (es) |
BR (1) | BR9814756A (es) |
CA (1) | CA2311930A1 (es) |
DE (1) | DE69828527T2 (es) |
HU (1) | HUP0004405A3 (es) |
ID (1) | ID24185A (es) |
IL (1) | IL136144A0 (es) |
NO (1) | NO20002720L (es) |
NZ (1) | NZ504354A (es) |
PL (1) | PL340926A1 (es) |
RU (1) | RU2216316C2 (es) |
SE (1) | SE9704401D0 (es) |
SK (1) | SK6592000A3 (es) |
TW (1) | TW570813B (es) |
WO (1) | WO1999027913A1 (es) |
ZA (1) | ZA9810465B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
SE9704401D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | Matrix pellets for greasy, oily or sticky drug substances |
IT1319202B1 (it) | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per le malattie a base infiammatoria. |
US6462021B1 (en) | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
AR035216A1 (es) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
SE0201658D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Immediate release pharmaceutical formulation |
JP3887588B2 (ja) * | 2002-08-30 | 2007-02-28 | 株式会社リガク | X線回折による応力測定法 |
US8986737B2 (en) | 2002-09-05 | 2015-03-24 | Wm. Marsh Rice University | Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth |
PT1569912E (pt) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia |
US20070059358A1 (en) * | 2003-07-02 | 2007-03-15 | Tianjin Tasly Pharmaceutical Co., Ltd., China | Matrix adjuvants and the drop pills prepared with them |
WO2008008120A1 (en) * | 2006-07-14 | 2008-01-17 | Fmc Corporation | Solid form |
AU2014201170B2 (en) * | 2006-12-20 | 2015-09-24 | Mylan Pharmaceuticals Ulc | Pharmaceutical composition comprising a hot-melt granulated lubricant |
EP2114455A4 (en) * | 2006-12-20 | 2010-03-17 | Mylan Pharmaceuticals Ulc | PHARMACEUTICAL COMPOSITION USING A HOT-MELT GRANULATED AGENT |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
KR102505172B1 (ko) | 2013-09-19 | 2023-02-28 | 마이크로벤션, 인코포레이티드 | 중합체 필름 |
CA2923753C (en) | 2013-09-19 | 2021-10-12 | Terumo Corporation | Polymer particles |
US9688788B2 (en) | 2013-11-08 | 2017-06-27 | Terumo Corporation | Polymer particles |
CN104133014B (zh) * | 2014-07-16 | 2015-09-16 | 广州法尔麦兰药物技术有限公司 | 一种考察布洛伪麻缓释制剂释放度的方法 |
WO2016154592A1 (en) | 2015-03-26 | 2016-09-29 | Microvention, Inc. | Embiolic particles |
KR102162370B1 (ko) | 2016-09-28 | 2020-10-06 | 테루모 가부시키가이샤 | 중합체 입자 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE557670C (de) | 1932-08-26 | Friedrich Rittershausen | Abtast- bzw. Bildzusammensetzvorrichtung | |
DE454386C (de) | 1924-05-27 | 1928-01-06 | Chemische Produkte Vormals H S | Verfahren zur Herstellung pharmazeutischer und diaetetischer Praeparate in kugelaehnlicher Form |
US2699054A (en) | 1953-10-09 | 1955-01-11 | Lloyd H Conover | Tetracycline |
DE2251197C3 (de) | 1972-10-19 | 1980-05-08 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von hxxochdosierten Tabletten von Tetracyclin- Derivaten |
GB8613689D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
DE3636123A1 (de) * | 1986-10-23 | 1988-05-05 | Rentschler Arzneimittel | Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten |
US5051261A (en) * | 1987-11-24 | 1991-09-24 | Fmc Corporation | Method for preparing a solid sustained release form of a functionally active composition |
DE3871343D1 (de) * | 1987-11-25 | 1992-06-25 | American Cyanamid Co | System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridin-calciumantagonisten. |
US5876754A (en) * | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
WO1993013757A1 (de) * | 1992-01-17 | 1993-07-22 | Alfatec-Pharma Gmbh | Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung |
ATE179606T1 (de) * | 1992-02-25 | 1999-05-15 | Spirig Ag | Minocyclin enthaltende pellets |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
SE9704401D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | Matrix pellets for greasy, oily or sticky drug substances |
-
1997
- 1997-11-28 SE SE9704401A patent/SE9704401D0/xx unknown
-
1998
- 1998-10-27 TW TW087117778A patent/TW570813B/zh active
- 1998-11-16 ZA ZA9810465A patent/ZA9810465B/xx unknown
- 1998-11-16 AR ARP980105800A patent/AR016684A1/es not_active Application Discontinuation
- 1998-11-18 IL IL13614498A patent/IL136144A0/xx unknown
- 1998-11-18 ID IDW20000913A patent/ID24185A/id unknown
- 1998-11-18 HU HU0004405A patent/HUP0004405A3/hu unknown
- 1998-11-18 US US09/214,317 patent/US6555138B1/en not_active Expired - Fee Related
- 1998-11-18 SK SK659-2000A patent/SK6592000A3/sk unknown
- 1998-11-18 PL PL98340926A patent/PL340926A1/xx unknown
- 1998-11-18 DE DE69828527T patent/DE69828527T2/de not_active Expired - Lifetime
- 1998-11-18 BR BR9814756-0A patent/BR9814756A/pt not_active IP Right Cessation
- 1998-11-18 KR KR1020007005803A patent/KR20010032558A/ko not_active Application Discontinuation
- 1998-11-18 NZ NZ504354A patent/NZ504354A/en unknown
- 1998-11-18 EP EP98957269A patent/EP1032371B1/en not_active Expired - Lifetime
- 1998-11-18 RU RU2000113730/14A patent/RU2216316C2/ru not_active IP Right Cessation
- 1998-11-18 CN CN98811637A patent/CN1280493A/zh active Pending
- 1998-11-18 AT AT98957269T patent/ATE286382T1/de not_active IP Right Cessation
- 1998-11-18 CA CA002311930A patent/CA2311930A1/en not_active Abandoned
- 1998-11-18 WO PCT/SE1998/002090 patent/WO1999027913A1/en active IP Right Grant
- 1998-11-18 JP JP2000522899A patent/JP2001524514A/ja active Pending
- 1998-11-19 AU AU13564/99A patent/AU746324B2/en not_active Ceased
-
2000
- 2000-05-26 NO NO20002720A patent/NO20002720L/no unknown
-
2003
- 2003-03-11 US US10/385,926 patent/US20030175352A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SK6592000A3 (en) | 2001-01-18 |
SE9704401D0 (sv) | 1997-11-28 |
BR9814756A (pt) | 2000-10-03 |
EP1032371B1 (en) | 2005-01-05 |
AU746324B2 (en) | 2002-04-18 |
US20030175352A1 (en) | 2003-09-18 |
ZA9810465B (en) | 1999-05-21 |
PL340926A1 (en) | 2001-03-12 |
NO20002720L (no) | 2000-07-28 |
US6555138B1 (en) | 2003-04-29 |
HUP0004405A2 (hu) | 2001-08-28 |
NO20002720D0 (no) | 2000-05-26 |
CN1280493A (zh) | 2001-01-17 |
RU2216316C2 (ru) | 2003-11-20 |
DE69828527D1 (de) | 2005-02-10 |
CA2311930A1 (en) | 1999-06-10 |
TW570813B (en) | 2004-01-11 |
DE69828527T2 (de) | 2005-12-29 |
HUP0004405A3 (en) | 2004-03-29 |
KR20010032558A (ko) | 2001-04-25 |
WO1999027913A1 (en) | 1999-06-10 |
ATE286382T1 (de) | 2005-01-15 |
AU1356499A (en) | 1999-06-16 |
EP1032371A1 (en) | 2000-09-06 |
NZ504354A (en) | 2001-12-21 |
IL136144A0 (en) | 2001-05-20 |
JP2001524514A (ja) | 2001-12-04 |
ID24185A (id) | 2000-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR016684A1 (es) | Composicion seca y solida para administracion de farmacos, proceso para su preparacion y el uso de una pluralidad de perlas que contienen una matrizpolimerica para la elaboracion de dicha composicion. | |
Isaev et al. | Neurotoxic glutamate treatment of cultured cerebellar granule cells induces Ca2+-dependent collapse of mitochondrial membrane potential and ultrastructural alterations of mitochondria | |
FI94094B (fi) | Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle | |
ATE19589T1 (de) | Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung. | |
ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
NO870558D0 (no) | Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat. | |
ATE226815T1 (de) | Herstellung von arzneimitteln | |
ES2189803T3 (es) | Procedimiento. | |
FI863889A (fi) | Farmaceutisk produkt som laongsamt friger aktivt aemne. | |
CY1105051T1 (el) | Παρασκευασμα σε μορφη υμενιου για τη διφασικη απελευθερωση ουσιων με φαρμακολογικη δραση ή αλλων ουσιων | |
DE68907139D1 (de) | Mikrokapsel mit verzoegerter freigabe fuer wasserloesliche arzneistoffe. | |
DK0904110T3 (da) | Nitrogenoxid-afgivende sammensætninger til nedsættelse af lægemidlers toksicitet | |
KR880004804A (ko) | 분무건조 아세트 아미노펜 | |
KR900015715A (ko) | 약물을 함유하는 동결건조 제형물의 제조방법 | |
KR880009639A (ko) | 서방성 매트릭스 제형 | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
SE9704400D0 (sv) | Porous inorganic particles as carriers for drug substances | |
ES544649A0 (es) | Procedimiento para la preparacion de etofibrato o compuestossimilares que contienen microgranulos de liberacion constan-te | |
ES2058228T3 (es) | Compuestos activos sobre el sistema cardiovascular. | |
ES2173739T3 (es) | Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion. | |
ES2095987T3 (es) | Sistema terapeutico transdermal para la administracion de farmacos que tienen actividad broncodilatadora. | |
ES2053535T3 (es) | Derivados heterociclicos de cinco miembros de n,n'-diacilhidrazinas n' sustituidas. | |
Safran et al. | Selective neurotoxicity induced by lasalocid in dissociated cerebral cultures | |
CO4980890A1 (es) | Una composicion antimalarica metodo para tratar la malaria | |
GT199700113A (es) | Tetrahidro - 6h - pirazino ( 1, 2 - b ) isoquinolin - 1, 4 - dionas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |